Porphyromonas gingivalis is a gram-negative anaerobic bacillus and one of the 500 different species of naturally occurring bacteria in the oral cavity. The bacterium, a known periodontopathogen, has been reported to be involved in cardiovascular diseases in subjects with periodontitis (1, 2) . Proposed mechanisms include systemic release of antigen like P.
gingivalis lipopolysaccharide (LPS) or endotoxin from infected periodontal pockets (3), or local persistent inflammation leading to modulation of systemic cytokine levels (4) and/or ability of the bacterium to invade endothelial cells (5) and blood vessels rendering bacteremia (6) . The LPS of P. gingivalis is also known to be associated with the development of periodontal diseases (7) and has also been postulated to be a predisposing factor for atherosclerotic diseases (8) .
Phenol/water-extracted P. gingivalis LPS is the ligand for cell surface toll-like receptors (TLR), TLR2 and TLR4 (9) , and stimulation of either TLR2 or TLR4 can result in activation of phosphoinositide-3-kinase/Akt-dependent signaling (10), which has been shown to protect myocytes from ischemic reperfusion injury (11) . We hypothesized that pre-treatment with P.
gingivalis LPS at appropriate concentrations would induce cardio-protection against injury induced by ischemia and reperfusion. Ca 2+ homeostasis is essential to contractile function of the heart and protection against cardiac injury. When an action potential arrives, the sarcolemmal membrane of cardiac myocyte is depolarized. homeostasis, which may alter its cytosolic Ca 2+ homeostasis and hence the contractile function.
In the present study we first attempted to test the hypothesis that sublethal dose of P.
gingivalis LPS pre-treatment may protect the heart against ischemic insult. We studied the effects of hot phenol-water extracted P. gingivalis LPS on infarct size of the rat heart subjected to ischemia and reperfusion using the Langendorff isolated perfused heart preparation. In the second series of experiments we attempted to test the hypothesis that P. gingivalis LPS 
Materials and Methods

Study design
To test the first hypothesis the effects of 24 h pretreatment with hot phenol-water extracted P. ] i . So the amount, the amplitude, and the rate, time to peak, of Ca 2+ released determine the contractility. The decay, 50% decay, reflects the removal of Ca 2+ from the cytosol and determines relaxation. A previous study from our lab showed that the amplitude of the transient is directly correlated to the shortening of the isolated ventricular myocyte (13) .
Preparation of P. gingivalis LPS
The hot phenol-water extraction method (14) was adopted to prepare P. gingivalis LPS. P.
gingivalis type strain ATCC 33277 was anaerobically cultured in tryptic soy broth supplemented with 1 mg/mL yeast extract, 5 µg/mL of hemin, and 1 µg/mL menadione. At mid-log phase growth (OD at 660 nm = 0.35), the bacteria were harvested by centrifugation (10,000 × g), and
washed twice in phosphate buffered saline. One gram of cells was suspended in 17.5 mL of water, boiled for 30 min, and disrupted by ultrasonication on ice; 15 mL of this suspension was then mixed with 15 mL of a 50% (v/v) solution of phenol (in the form of 90% phenol crystals) and double-distilled water pre-warmed to 68°C. The mixture was incubated at 68°C with A protein assay was performed to confirm the purity of the extracted LPS, and no detectable protein was found in the sample. DNA content of the extracted LPS was analyzed by PCR using P. gingivalis specific (15) or universal 16S rDNA primers (16) . Detection limits of both protocols were ≥ 0.00001% or 0.0001% of DNA by weight, respectively. No P. gingivalis DNA nor any bacterial 16S rDNA was detectable. Lipid A was extracted from the LPS as described previously (17) and subjected to matrix-assisted laser desorption ionization-time of flight mass spectrometry analysis at the Genome Research Centre, The University of Hong
Kong. The species of lipid A in the preparation was identified as P. gingivalis triacylated lipid A, as described in the literature (18) . No attempt was made to characterize the level of contaminating cell surface polysaccharides in the preparation.
Animal experiments
The study was approved by the Committee on the Use of Live Animals in Teaching and ] i ) transients in isolated rat ventricular myocyte (Fig. 1B) .
P. gingivalis LPS pre-treatment and rat heart ischemia/reperfusion Twenty-four hours after the injections, all rats were anesthetized with intra-peritoneal 60 mg/kg sodium pentobarbitone and then injected with 200 IU of heparin intravenously. Hearts were excised rapidly and placed in ice-cold Krebs-Henseleit perfusion buffer (11 mM glucose, 118 mM NaCl, 4.7 mM KCl, 1.25 mM CaCl 2 , 1.2 mM MgSO 4 , 25 mM NaHCO 3 , 1.2 mM KH 2 PO 4 ) before being mounted on a Langendorff apparatus for perfusion at 37°C with perfusion buffer at a constant pressure (100 cm H 2 O) and equilibrated with 95% O 2 and 5% CO 2 .
The hearts were allowed to stabilize for 30 min and then subjected to regional ischemia and reperfusion as described previously (21) . Any hearts exhibiting arrhythmia during stabilization were discarded. A 3-O silk suture was placed around the left anterior descending coronary artery from the area immediately below the left atrial appendage to the right portion of the left ventricle. The ends of the suture were threaded through a propylene tube to form a snare. The left anterior descending coronary artery was occluded by pulling the ends of the suture taut and using a hemostat to clamp the snare onto the pericardial surface for 30 min. Ischemia was verified by regional cyanosis and a substantial decrease in coronary flow. Reperfusion was achieved by releasing the ligature and the heart was reperfused for 120 min to induce myocardial injury (21) .
After the reperfusion, the ligature was re-tightened and approximately 0.2 mL of 2.5%
Evans blue dye (Sigma Chemical, St. Louis, MO, USA) was infused into the heart through the jugular vein to stain any permeable tissue, leaving non-perfused vascular (occluded and at risk of infarction) tissue uncolored. Excess dye was washed off, and the hearts were frozen and sectioned into slices of 3 to 4 mm and then incubated with sodium phosphate buffer containing by receiving an intra-peritoneal 0.5 mg/kg dose of P. gingivalis LPS dissolved in 2 mL saline 24 h before the experiment, whereas the control group received the saline injection only. This dose was chosen as it was shown to confer a cardio-protective effect to ischemia/reperfusion insults in the isolated heart in the first series of experiments.
Twenty-four hours after the injection, the rats were anesthetized with intra-peritoneal 60 mg/kg sodium pentobarbitone and decapitated. Ventricular myocytes were then isolated from the hearts of the rats using the collagenase method as described previously (22) . The heart was mounted on an apparatus that allowed retrograde perfusion through the aorta with 0.2% collagenase and 0.03% protease dissolved in Tyrode's solution (5 mM glucose, 143 mM NaCl, 
Statistical analyses
Data were expressed as mean ± standard error of the mean (SEM). Statistical comparisons of the infarct size were performed by one-way analysis of variance followed by Tukey's multiple 
Results
Effects of P. gingivalis LPS pre-conditioning on myocardial injury
Myocardial infarction was induced in all the rat hearts in which the coronary artery had been occluded. Pre-treatment with low doses of P. gingivalis LPS resulted in reductions in infarct size and the reduction induced by 0.5 mg/kg P. gingivalis LPS was statistically significant. In contrast, pre-conditioning with P. gingivalis LPS at higher doses increased the infarct size significantly (Fig. 2) .
Effects of P. gingivalis LPS pre-conditioning on rat ventricular myocytes
Because 24-h pre-conditioning with 0.5 mg/kg P. gingivalis LPS conferred cardio-protection against injury induced by ischemia and reperfusion, we determined the effects of this pre-conditioning protocol on the resting [Ca 2+ ] i and its transient, which reflects Ca 2+ handling and contractile functions (Fig. 3) . In brief, the control myocyte showed a greater reduction in (Figs. 3 and 7) . The corresponding value in the treatment group during ischemia was significantly lower than that in the control group. and LPSs are known to recognize and bind to TLR2 and TLR4 to elicit cellular responses (29, 30) . Phenol/water-extracted P. gingivalis LPS is the ligand for TLR2 and TLR4 (9), whereas the pure form of the LPS from E. coli is the ligand for TLR4 only (9, 31) . Stimulation of either TLR2 or TLR4 can result in activation of phosphoinositide-3-kinase/Akt-dependent signaling (10), which has been shown to protect myocytes from ischemic reperfusion injury (11) . TLR2 is believed to be cardio-protective against oxidative stress in neonatal rat cardiac myocytes (28) .
The relative contributions of TLR2 or TLR4 in the host response to P. gingivalis LPS challenge are yet to be characterized.
P. gingivalis LPS pre-treatment was administered intra-peritoneally to test animals-an
established and convenient administration method. Abdulla and co-workers (32) previously reported on the bioavailability of E. coli LPS after intra-peritoneal administration. In brief, the rat serum endotoxin concentration peaked at 6 h to a level of 10 ng/mL after intra-peritoneal injection of 25 µg of E. coli LPS, meaning that 0.4% of what was administered entered the systemic circulation. These observations are explained by hepatic first-pass and liver clearance of LPS (33) , in which combined actions of Kupffer cells, CD14, and LPS-binding proteins result in highly effective detoxification of the administered LPS (34, 35) . We estimate that a M a n u s c r i p t p r o o f 17 exposure to LPS from periodontopathogens, nevertheless would be highly probable in human with advanced periodontitis in which P. gingivalis LPS directly enters the systemic circulation through inflamed ulcerated periodontal pockets (36) .
Although this study was performed in rats to closely related models, extrapolation of the deleterious effects of P. gingivalis LPS in periodontitis, such as affecting systemic or cardiac health, clinical settings for humans should be made with caution. Furthermore, we used phenol/water-extracted P. gingivalis LPS, so further research to study the effects of column-purified P. gingivalis LPS on heart tissue as well as the possible mechanisms of host-LPS interactions are needed.
The delayed nature of protection suggests that cardio-protective proteins may be synthesized de novo. Three classes of proteins are known to be end-effectors responsible for delayed cardio-protection after pre-conditioning: heat-shock protein families (37-39); intracellular antioxidant enzymes, including catalase (19) and superoxide dismutase (40, 41);
and inducible nitric oxide synthase (42, 43) . P. gingivalis LPS has been shown to be able to enhance expression of the cardio-protective superoxide dismutase in human monocytic cell lines (44) . Further study on the contribution of this protein to the cardio-protective action of P.
gingivalis LPS is warranted.
Paradoxically, when the dose of P. gingivalis LPS increased to between 1 and 4 mg/kg, myocardial injury was exacerbated and the infarct size increase significantly. Similarly, high-dose E. coli LPS, in contrast to a low dose, can induce TLR4-mediated NF-κB activation, trigger transcription of inflammatory mediators (45) , and induce cardiac dysfunction (46, 47) .
The same phenomena might be in action during challenge with a higher dose of P. gingivalis
LPS.
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Conclusion
We demonstrate for the first time that phenol/water-extracted P. gingivalis LPS given intra-peritoneally has biphasic effects on cardiac injury induced by ischemia/reperfusion in the rat heart 24 h after its administration. A sublethal intra-peritoneal dose (0.5 mg/kg) of P. Myocytes were stabilized for 30 min before being subjected to 10 min of metabolic inhibition and anoxia (MI/A) with 10 mM 2-deoxy-D-glucose and 10 mM sodium dithionite in glucose-free Krebs solution, followed by 20-min reperfusion. and during ischemia (metabolic inhibition and anoxia; MI/A), and at the end of reperfusion.
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